3 | 1217512-35-0 | R51211-d3 | 伊曲康唑-d3 | 依他康唑-d3 | Antibiotic | Fungal | Autophagy | Hedgehog | Bacterial | Cytochrome P450 | CYPs | Inhibitor | inhibitor | inhibit"/>

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  1. Anti-infection Metabolic Enzyme/Protease Autophagy Stem Cell/Wnt
  2. Antibiotic Fungal Autophagy Hedgehog Bacterial Cytochrome P450
  3. Itraconazole-d3

Itraconazole-d3  (Synonyms: 伊曲康唑 -d3; R51211-d3)

目錄號: HY-17514S1 純度: 99.62%
COA 產(chǎn)品使用指南

Itraconazole-d3Itraconazole (HY-17514) 的氘代物。

MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)

Itraconazole-d<sub>3</sub> Chemical Structure

Itraconazole-d3 Chemical Structure

CAS No. : 1217512-35-0

1.  客戶無需承擔(dān)相應(yīng)的運輸費用。

2.  同一機構(gòu)(單位)同一產(chǎn)品試用裝僅限申領(lǐng)一次,同一機構(gòu)(單位)一年內(nèi)

     可免費申領(lǐng)三個不同產(chǎn)品的試用裝。

3.  試用裝只面向終端客戶。

規(guī)格 價格 是否有貨 數(shù)量
1 mg ¥3900
In-stock
5 mg 現(xiàn)貨 詢價
10 mg   詢價  
50 mg   詢價  

* Please select Quantity before adding items.

Customer Review

Other Forms of Itraconazole-d3:

  • 生物活性

  • 純度 & 產(chǎn)品資料

  • 參考文獻

生物活性

Itraconazole-d3 is the deuterium labeled Itraconazole (HY-17514)[1].

細胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
> 30 μM
Compound: ITC
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 96 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 96 hrs by MTT assay
[PMID: 34388384]
A549 IC50
> 50 μM
Compound: 2; ILC
Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
[PMID: 34749201]
A549 IC50
182 μg/mL
Compound: IT
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
[PMID: 24513049]
A549 IC50
3 μM
Compound: Itraconazole
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
[PMID: 36184028]
C3H 10T1/2 IC50
0.063 μM
Compound: 1; ITZ
Inhibition of hedgehog pathway in mouse C3H10T1/2 cells assessed as downregulation of Gli1 mRNA expression after 24 hrs by qPCR method
Inhibition of hedgehog pathway in mouse C3H10T1/2 cells assessed as downregulation of Gli1 mRNA expression after 24 hrs by qPCR method
[PMID: 27014922]
CHO IC50
> 40 μM
Compound: 2
Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
Inhibition of human ERG expressed in CHO cells by whole-cell patch clamp assay
[PMID: 24564525]
HEK293 IC50
> 250 μM
Compound: Itraconazole
Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay
Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay
[PMID: 29626797]
HEK-293T IC50
> 50 μM
Compound: 2; ILC
Cytotoxicity against human HEK293T cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
Cytotoxicity against human HEK293T cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
[PMID: 34749201]
Hepatocyte IC50
0.07 μM
Compound: Itraconazole
Inhibition of CYP3A4 in human hepatocytes using testosterone as substrate by HPLC/MS/MS method
Inhibition of CYP3A4 in human hepatocytes using testosterone as substrate by HPLC/MS/MS method
[PMID: 24948565]
HepG2 IC50
> 50 μM
Compound: 2; ILC
Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
[PMID: 34749201]
HepG2 IC50
142 μg/mL
Compound: IT
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
[PMID: 24513049]
HepG2 IC50
7.87 μM
Compound: Itraconazole
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
[PMID: 36184028]
HT-1080 IC50
201.63 μg/mL
Compound: IT
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
[PMID: 24513049]
HUVEC IC50
0.17 μM
Compound: 1
Anti-angiogenic activity against HUVEC after 24 hrs by scintillation counting based [3H]-thymidine incorporation assay
Anti-angiogenic activity against HUVEC after 24 hrs by scintillation counting based [3H]-thymidine incorporation assay
[PMID: 30481027]
HUVEC GI50
0.4 μM
Compound: 1; ITZ
Antiproliferative activity against HUVEC assessed as inhibition of VEGF induced cell proliferation after 72 hrs by MTS assay
Antiproliferative activity against HUVEC assessed as inhibition of VEGF induced cell proliferation after 72 hrs by MTS assay
[PMID: 27014922]
HUVEC IC50
160 nM
Compound: 1; ITZ
Antiproliferative activity against HUVEC assessed as inhibition of VEGF induced cell proliferation using methyl-[3H]thymidine after 36 hrs
Antiproliferative activity against HUVEC assessed as inhibition of VEGF induced cell proliferation using methyl-[3H]thymidine after 36 hrs
[PMID: 27014922]
HUVEC IC50
170 nM
Compound: 1
Inhibition of NPC1/VDAC1 in HUVEC cells assessed as reduction in cell proliferation pretreated for 24 hrs followed by [3H]thymidine incorporation by scintillation counter method
Inhibition of NPC1/VDAC1 in HUVEC cells assessed as reduction in cell proliferation pretreated for 24 hrs followed by [3H]thymidine incorporation by scintillation counter method
[PMID: 32550989]
L02 IC50
> 50 μM
Compound: Itraconazole
Cytotoxicity against human L02 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
[PMID: 36184028]
LLC-PK1 IC50
0.2 μM
Compound: Itraconazole
Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
[PMID: 12699389]
LLC-PK1 IC50
0.7 μM
Compound: Itraconazole
Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
[PMID: 12699389]
LLC-PK1 IC50
2.1 μM
Compound: Itraconazole
Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
[PMID: 12699389]
MCF-10A IC50
> 300 μM
Compound: IT
Cytotoxicity against human MCF10A cells after 48 hrs by WST1 assay
Cytotoxicity against human MCF10A cells after 48 hrs by WST1 assay
[PMID: 24513049]
MCF7 IC50
> 30 μM
Compound: ITC
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 96 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 96 hrs by MTT assay
[PMID: 34388384]
MCF7 IC50
> 50 μM
Compound: 2; ILC
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth incubated for 4 hrs by MTT assay
[PMID: 34749201]
Medulloblastoma cell GI50
0.44 μM
Compound: 1; ITZ
Antiproliferative activity against mouse MERP MB cells assessed as cell growth inhibition using methyl-[3H]thymidine after 48 hrs by liquid scintillation spectrophotometry
Antiproliferative activity against mouse MERP MB cells assessed as cell growth inhibition using methyl-[3H]thymidine after 48 hrs by liquid scintillation spectrophotometry
[PMID: 27014922]
PBMC IC50
1.53 μM
Compound: Itraconazole
Cytotoxicity against human PBMC assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against human PBMC assessed as cell viability after 72 hrs by MTT assay
[PMID: 24485783]
THLE-2 IC50
> 30 μM
Compound: ITC
Cytotoxicity against human THLE-2 cells assessed as reduction in cell viability measured after 96 hrs by MTT assay
Cytotoxicity against human THLE-2 cells assessed as reduction in cell viability measured after 96 hrs by MTT assay
[PMID: 34388384]
Vero IC50
> 50 μg/mL
Compound: ITZ
Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
[PMID: 23831506]
分子量

708.65

Formula

C35H35D3Cl2N8O4

CAS 號
非標(biāo)記 CAS
性狀

固體

顏色

White to off-white

中文名稱

伊曲康唑-d3;依他康唑-d3

運輸條件

Room temperature in continental US; may vary elsewhere.

儲存方式
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
溶解性數(shù)據(jù)
細胞實驗: 

DMSO 中的溶解度 : ≥ 0.5 mg/mL (0.71 mM; 吸濕的 DMSO 對產(chǎn)品的溶解度有顯著影響,請使用新開封的 DMSO)

DMF 中的溶解度 : ≥ 0.5 mg/mL (0.71 mM)

* "≥" means soluble, but saturation unknown.

  • 摩爾計算器

  • 稀釋計算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質(zhì)量
=
濃度
×
體積
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

濃度 (start)

C1

×
體積 (start)

V1

=
濃度 (final)

C2

×
體積 (final)

V2

動物溶解方案計算器
請輸入動物實驗的基本信息:

給藥劑量

mg/kg

動物的平均體重

g

每只動物的給藥體積

μL

動物數(shù)量

由于實驗過程有損耗,建議您多配一只動物的量
計算結(jié)果
工作液所需濃度 : mg/mL
純度 & 產(chǎn)品資料
參考文獻
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的產(chǎn)品:

Your information is safe with us. * Required Fields.

   產(chǎn)品名稱:

 

* 需求量:

* 客戶姓名:

 

* Email:

* 電話:

 

* 公司或機構(gòu)名稱:

   留言給我們:

Bulk Inquiry

Inquiry Information

產(chǎn)品名稱:
Itraconazole-d3
目錄號:
HY-17514S1
需求量: